Stock AIM AIM IMMUNOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases AIM ImmunoTech Inc.

Equities

AIM

US00901B1052

Market Closed - Nyse
Other stock markets
 04:10:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.4282 USD +5.34% Intraday chart for AIM ImmunoTech Inc. -7.91% -2.66%
Apr. 10 AIM Immunotech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer CI
Apr. 02 Transcript : AIM ImmunoTech Inc., Q4 2023 Earnings Call, Apr 02, 2024

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
GL
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
GL
AIM ImmunoTech Announces Charles Lapp, MD, as a Consulting Medical Officer for its ME/CFS and Long COVID Programs
GL
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
GL
AIM ImmunoTech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer
GL
Challenges To Advance Notice Bylaws Are Spiking
AQ
AIM ImmunoTech Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
GL
AIM ImmunoTech to Present at the MedInvest Biotech & Pharma Investor Conference
GL
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
GL
AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
AQ
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
AQ
AIM ImmunoTech Announces Publication of Positive Findings from a Study Evaluating Ampligen® in the Treatment of Pancreatic Cancer in the Journal Clinical Cancer Research
GL
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
GL
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
GL
AIM ImmunoTech Announces Release of the Next CEO Corner Segment
AQ
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity
GL
AIM ImmunoTech to Participate in the Virtual Investor Lunch Break: The AIM Opportunity
AQ
AIM ImmunoTech Announces Launch of CEO Corner Platform
GL
AIM ImmunoTech Announces Launch of CEO Corner Platform
AQ
AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AIM Stock
  4. News AIM ImmunoTech Inc.
  5. Press Releases